ACHV Stock Analysis: Buy, Sell, or Hold?
ACHV - Achieve Life Sciences, Inc.
$7.99
-0.03 (-0.37%)
▼
5d:
+5.27%
30d:
+29.5%
90d:
+73.7%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When ACHV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ACHV shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ACHV shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ACHV is currently trading at $7.99, which is considered extended relative to its 30-day fair value range of $6.03 to $7.27.
Technical Outlook: Technically, ACHV is in a strong uptrend. Immediate support is located at $6.51, while resistance sits at $8.61.
Market Sentiment: ACHV scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.83 (+73.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACHV is in a strong uptrend. Immediate support is located at $6.51, while resistance sits at $8.61.
Market Sentiment: ACHV scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.83 (+73.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$6.03 -
$7.27
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range (+9.9% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 73.1% below Wall St target ($13.83)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$6.03 -
$7.27
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$6.51
Resistance Level
$8.61
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.65
Wall Street Target
$13.83
(+73.1%)
Share & Embed Analysis
Last updated: August 22, 2026 8:31 PM ET
Data refreshes hourly during market hours. Next update: 9:31 PM
Data refreshes hourly during market hours. Next update: 9:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACHV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 42 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 66 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 52 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$125 | 41 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 35 SELL |
